Name: USCAP 2025 Contemporary Issues in Breast Pathology
Brand: Medical Education Hub
SKU: MED-AMB04405
Price: 65.0 EUR
Availability: InStock

USCAP 2025 Contemporary Issues in Breast Pathology

€65,00

Tax included. Shipping calculated at checkout.

Free Shipping on orders over 45$

In stock, ready to ship
Inventory on the way

Original release date: July 28, 2025

Course Description
USCAP 2025 Contemporary Issues in Breast Pathology This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
Discuss prognostic and predictive assays in patients with breast cancer

Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document

Update on Classification and Management of LCIS – Stuart Schnitt, MD

Section: 1 Presentation 1 Document

Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD

Section: 1 Presentation 1 Document

Digital Slides: Small Glandular Proliferations – Laura Collins, MD

Section: 1 Presentation 1 Document

Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Papillary Proliferations – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document

Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document

Apocrine Proliferations – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD

Section: 1 Presentation 2 Documents

Spindle Cell Lesions – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Vascular Lesions – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document 1 Certificate 1 Survey
Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document
Special Type Triple Negative Breast Cancers – Laura Collins, MD

Section: 1 Presentation 1 Document
HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD

Section: 1 Presentation 2 Documents
Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document
Specimen Handling and Margin Evaluation – Laura Collins, MD

Section: 1 Presentation 1 Document
Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document
Uncommon Clinical Scenarios – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document
Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Applications of AI to Breast Pathology – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
FREE SECTION: Panel Discussion and Q&A

Section: 8 Presentations

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

Testimonials

★★★★★

“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain

★★★★★

”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia

★★★★★
Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.
I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.
Richard Dorge
Winnipeg, MB

USCAP 2025 Contemporary Issues in Breast Pathology

Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD

Update on Classification and Management of LCIS – Stuart Schnitt, MD

Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD

Digital Slides: Small Glandular Proliferations – Laura Collins, MD

Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath

Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath

Papillary Proliferations – Edi Brogi, MD, PhD

Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD

Apocrine Proliferations – Cecily Quinn, MD, FRCPath

Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD

Spindle Cell Lesions – Cecily Quinn, MD, FRCPath

Vascular Lesions – Gregory Bean, MD, PhD

Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD

Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD

Special Type Triple Negative Breast Cancers – Laura Collins, MD

HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD

Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD

Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD

Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD

Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD

Specimen Handling and Margin Evaluation – Laura Collins, MD

Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD

Uncommon Clinical Scenarios – Edi Brogi, MD, PhD

Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD

Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD

Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD

Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD

Applications of AI to Breast Pathology – Stuart Schnitt, MD

FREE SECTION: Panel Discussion and Q&A

Testimonials

You may also like

Recently viewed

Currency

USCAP 2025 Contemporary Issues in Breast Pathology

Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD

Update on Classification and Management of LCIS – Stuart Schnitt, MD

Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD

Digital Slides: Small Glandular Proliferations – Laura Collins, MD

Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath

Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath

Papillary Proliferations – Edi Brogi, MD, PhD

Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD

Apocrine Proliferations – Cecily Quinn, MD, FRCPath

Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD

Spindle Cell Lesions – Cecily Quinn, MD, FRCPath

Vascular Lesions – Gregory Bean, MD, PhD

Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD

Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD

Special Type Triple Negative Breast Cancers – Laura Collins, MD

HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD

Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD

Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD

Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD

Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD

Specimen Handling and Margin Evaluation – Laura Collins, MD

Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD

Uncommon Clinical Scenarios – Edi Brogi, MD, PhD

Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD

Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD

Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD

Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD

Applications of AI to Breast Pathology – Stuart Schnitt, MD

FREE SECTION: Panel Discussion and Q&A

Testimonials

Sign up to get all the tei